Select your preferred language

By clicking on a specific language, you will be redirected to the local page of the region.

More regional pages are coming online soon.

To explore our full network, visit our Offices page.


Global
Canada
United States
London

Case Study

Boehringer Ingelheim

Having GPP is a Tough Job

  • SectorHealth & Wellness
  • OfficeCanada

General Pustular Psoriasis (GPP) is a rare and debilitating skin disease that may be life-threatening. Currently in Canada there are no approved prescription medications or treatment guidelines specifically for GPP.

Boehringer Ingelheim Canada (BI) developed Spesolimab, a prescription treatment for GPP that is currently being reviewed by Health Canada under its Priority Review Policy. In advance of Health Canada’s approval and availability in Canada, BI’s goal was to raise awareness of GPP.     We created an integrated, digital-first campaign that told Kate’s story navigating like with GPP. Key results included: 2.8 million impressions, 898,595 video views, 741,122 engagements and a total reach of 1.1 million.

Related Services and Sectors

Health & Wellness

We know the healthcare revolution is only transformational if it reaches everyone. United with the world’s leading brands, we leverage the power of communications to inform, engage and build trust for healthcare solutions across the world.

Discover